Abstract
Since July 1994, we have used microwave coagulo-necrotic therapy (MCN) for patients with hepatocellular carcinoma (HCC) in our institute. All our new patients were classified by prognostic staging system (CLIP score, JIS score, modified JIS score and Tokyo Score) and those survival rate were assessed.In each staging score, the cumulative survival rates in MCN group were almost equal to those in hepatic resection (Hr) group.Based on the above, it was suggested that MCN has the ability of loco-regional control of HCC and MCN can be a first choice for the treatment of HCC.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
